Form 4 · Filed Jun 5, 2026, 08:05 PM UTC
ANIK/Anika Therapeutics, Inc.
Griffin Stephen D. — President and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | M | other | 12,840 | — | — | 49,742 |
| Jun 3, 2026 | F | other | 3,769 | $14 | $54,311 | 45,973 |
| Jun 3, 2026 | M | other | 12,840 | — | — | 12,840 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-259520